173 related articles for article (PubMed ID: 32631353)
1. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma.
Zhang T; Shi W; Tian K; Kong Y
World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353
[TBL] [Abstract][Full Text] [Related]
2. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
[TBL] [Abstract][Full Text] [Related]
3. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
[TBL] [Abstract][Full Text] [Related]
4. Chaperonin-containing tailless complex polypeptide 1 subunit 6A correlates with increased World Health Organization grade, less isocitrate dehydrogenase mutation, and deteriorative survival of astrocytoma patients.
Hu Y; Fu P; Zhao H; Zhang F; Jiang X; Zhao W; Lv P
J Clin Lab Anal; 2021 Sep; 35(9):e23917. PubMed ID: 34312925
[TBL] [Abstract][Full Text] [Related]
5. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosis.
Cai Y; Wu D; Zhan L
Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101796. PubMed ID: 34500119
[TBL] [Abstract][Full Text] [Related]
6. CCT6A dysregulation in surgical prostate cancer patients: association with disease features, treatment information, and prognosis.
Peng S; Yu J; Wang Y
Ir J Med Sci; 2024 Feb; 193(1):85-93. PubMed ID: 37523068
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
8. The intercorrelation among CCT6A, CDC20, CCNB1, and PLK1 expressions and their clinical value in papillary thyroid carcinoma prognostication.
Peng W; Li W; Zhang X; Cen W; Liu Y
J Clin Lab Anal; 2022 Sep; 36(9):e24609. PubMed ID: 35838025
[TBL] [Abstract][Full Text] [Related]
9. CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
Wang N; Chen Y; Wu J
Oncol Lett; 2023 May; 25(5):201. PubMed ID: 37113398
[TBL] [Abstract][Full Text] [Related]
10. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
Chen H; Yan S; Dong L; Li X
J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
[TBL] [Abstract][Full Text] [Related]
11. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients.
Ye Q; Zhang M; Yin Y
J Clin Lab Anal; 2020 Apr; 34(4):e23141. PubMed ID: 31944409
[TBL] [Abstract][Full Text] [Related]
12. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
Liu Y; Tian J; Qin D; Liu J; Xie Y
J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.
Yan J; Wan D
J Clin Lab Anal; 2022 Feb; 36(2):e24140. PubMed ID: 34952984
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer.
Zhou Q; Fan G; Dong Y
J Clin Lab Anal; 2020 Apr; 34(4):e23152. PubMed ID: 31876063
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non-small-cell lung cancer patients.
Ke C; Long S
J Clin Lab Anal; 2022 Mar; 36(3):e24229. PubMed ID: 35106847
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 2 reflects exacerbated disease characteristics and poor prognosis in non-small cell lung cancer patients.
Lou N; Zhu T; Qin D; Tian J; Liu J
Ir J Med Sci; 2022 Feb; 191(1):155-162. PubMed ID: 33635447
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer.
Huang K; Zeng Y; Xie Y; Huang L; Wu Y
Mol Med Rep; 2019 May; 19(5):4344-4352. PubMed ID: 30942452
[TBL] [Abstract][Full Text] [Related]
19. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
Zhu M; Geng L; Shen W; Wang Y; Liu J; Cheng Y; Wang C; Dai J; Jin G; Hu Z; Ma H; Shen H
J Thorac Oncol; 2017 Apr; 12(4):644-656. PubMed ID: 28104536
[TBL] [Abstract][Full Text] [Related]
20. Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.
Li L; Xu B; Zhang H; Wu J; Song Q; Yu J
J Clin Lab Anal; 2020 Jan; 34(1):e23031. PubMed ID: 31713908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]